Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Repurchased
Ratios

Adma Biologics (ADMA) Long-Term Debt Issuances (2017 - 2025)

Adma Biologics' Long-Term Debt Issuances history spans 9 years, with the latest figure at -$75.0 million for Q4 2025.

  • For Q4 2025, Long-Term Debt Issuances changed N/A year-over-year to -$75.0 million; the TTM value through Dec 2025 reached $60.0 million, down 55.56%, while the annual FY2023 figure was $135.0 million, 11.04% down from the prior year.
  • Long-Term Debt Issuances reached -$75.0 million in Q4 2025 per ADMA's latest filing, down from $135.0 million in the prior quarter.
  • In the past five years, Long-Term Debt Issuances ranged from a high of $151.8 million in Q1 2022 to a low of -$75.0 million in Q4 2025.
  • Average Long-Term Debt Issuances over 3 years is $70.6 million, with a median of $135.0 million recorded in 2023.